Last reviewed · How we verify

NCT03879213: RRB3

Acute Berry Intake on Metabolic Control and Cognitive Function

Completed NA Last updated 14 July 2020
What this trial tests

NA trial testing Active breakfast in Healthy in 30 participants. Completed in 1 June 2020.

Timeline
17 September 2018
Primary endpoint
1 February 2020
1 June 2020

Quick facts

Lead sponsorClinical Nutrition Research Center, Illinois Institute of Technology
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeother
Enrollment30
Start date17 September 2018
Primary completion1 February 2020
Estimated completion1 June 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Clinical Nutrition Research Center, Illinois Institute of Technology — full company profile →

Who can join

Adults 55 to 70, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objectives of this study are: 1. Evaluate the effects of acute dietary raspberry intake on metabolic-associated impairments in cognitive and psychomotor function in overweight/obese adults (55-70y) following a meal challenge 2. Evaluate the effects of acute dietary raspberry on measures of vascular function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Active breakfast

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Clinical Nutrition Research Center, Illinois Institute of Technology trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03879213.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing